To view the fulltext, please log in
To view the pdf, please log in
Background: Psychiatric comorbidity in patients with skin disorders has been reported. Objective: To find out the prevalence of psychiatric disorders in dermatology outpatients and to investigate the factors that affect the psychiatric symptoms. Methods: 256 patients attending our dermatology outpatient clinic completed a 12-item General Health Questionnaire (GHQ) following their dermatologic examination. A standardized personal interview was performed to establish a psychiatric diagnosis in patients sampled by using a stratified random sampling method. Results: The prevalence of psychiatric disorders was found to be 33.4% in the study group. The mean of the total GHQ scores of the sample group (n = 256 patients) was 3.656. The duration of the dermatologic complaints, sex of the subjects, localization of the lesions, and dermatologic diagnosis did not affect the total GHQ scores of the patients. Conclusion: Psychiatric comorbidity in 33.4% of the dermatology outpatients indicates the need for considering emotional factors for an effective management of the cutaneous disorders.
Copyright / Drug Dosage
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
- Rodin G, Voshart K: Depression in the medically ill: An overview. Am J Psychiatry 1986;143:696–705.
- Hall RC, Rundell JR, Hirsch TW: Economic issues in consultation-liaison psychiatry; in Rundell JR, Wise MG (eds): Textbook of Consultation-Liaison Psychiatry. Washington, American Psychiatric Press, 1996, pp 24–37.
- Morris PLP, Robinson RG, Andrezejewski P, Samuels J, Price TR: Association of depression with 10-year poststroke mortality. Am J Psychiatry 1993;150:124–129.
- Lesperance F, Frasure-Smith N, Talajic M: Major depression before and after myocardial infarction: Its nature and consequences. Psychosom Med 1996;58:99–110.
- Hughes JE, Barraclough BM, Hamblin LG, White JE: Psychiatric symptoms in dermatology patients. Br J Psychiatry 1983;143:51–54.
- Wessely SC, Lewis GH: The classification of psychiatric morbidity in attenders at a dermatology clinic. Br J Psychiatry 1989;155: 686–691.
- Johnson FYA, Mostaghimi H: Comorbidity between dermatologic diseases and psychiatric disorders in Papua New Guinea. Int J Dermatol 1995;34:244–248.
- Goldberg D, Williams P: A User’s Guide to General Health Questionnaire: GHQ. Windsor, NFER-Nelson, 1988.
- Kılıç C: General Health Questionnaire: A validity and reliability study. Turk J Psychiatry 1996;7:3–9.
- Rezaki SM, Özgen G, Kaplan İ, Gürsoy BM, Sağduyu A, Öztürk OM: Results from the Ankara center; in Üstün TB, Sartorius N (eds): Mental Illness in General Health Care: An International Study. Chichester, Wiley, 1995, pp 39–56.
- Von Korff M, Üstün TB: Method of the WHO collaborative study on psychological problems in general health care; in Üstün TB, Sartorius N (eds): Mental Illness in General Health Care: An International Study. Chichester, Wiley, 1995, pp 19–38.
- Sorias S, Saygılı R, Elbi H, Vahip S, Mete L, Zifirne Z: Structured clinical interview for DSM-III-R: User’s Guide in Turkish. İzmir, Ege Üniversitesi Matbaası, 1988.
- Gupta MA, Gupta AK: Psychodermatology: An update. J Am Acad Dermatol 1996;34: 1030–1046.
- Gupta MA, Gupta AK, Schork NJ, Ellis CN: Depression modulates pruritus perception: A study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med 1994;56:36–40.
- Gupta MA: Evaluation and treatment of ‘psychogenic’ pruritus and self-excoriation (letter). J Am Acad Dermatol 1995;32:532–533.
- Cohen-Cole SA, Kaufman KG: Major depression in physical illness: Diagnosis, prevalence, and antidepressant treatment (a ten-year review: 1982–1992). Depression 1993;1: 181–204.
- Colon EA, Popkin MK: Anxiety and panic; in Rundell JR, Wise MG (eds): Textbook of Consultation-Liaison Psychiatry. Washington, American Psychiatric Press, 1996, pp 402–425.
- Burvill PW: The epidemiology of psychological disorders in general medical settings; in Sartorius N, Goldberg D, DeGiroloma G, Silva JAC, Lecrubier Y, Wittchen HU (eds): Psychological Disorders in General Medical Settings. Toronto, Hogrefe & Huber, 1990, pp 9–20.